Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17251130 | Method and Apparatus for Ultrasound Imaging with Improved Beamforming | December 2020 | March 2025 | Abandon | 51 | 1 | 0 | No | No |
| 17031786 | METHODS AND APPARATUS FOR CONFIGURING AN ULTRASOUND SYSTEM WITH IMAGING PARAMETER VALUES | September 2020 | February 2025 | Abandon | 52 | 3 | 1 | Yes | No |
| 17027675 | TEMPERATURE MEASUREMENT METHOD AND MEASUREMENT DEVICE | September 2020 | March 2024 | Abandon | 42 | 2 | 1 | No | No |
| 16986681 | ULTRASOUND DIAGNOSIS APPARATUS AND OPERATING METHOD THEREOF FOR DISPLAYING ULTRASOUND ELASTICITY IMAGES | August 2020 | July 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 16967929 | ULTRASOUND BLOOD-FLOW MONITORING | August 2020 | July 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 16963553 | GUIDED-TRANSCRANIAL ULTRASOUND IMAGING USING NEURAL NETWORKS AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | July 2020 | June 2024 | Abandon | 47 | 4 | 0 | Yes | No |
| 16898635 | ULTRASOUND DIAGNOSIS APPARATUS AND PROGRAM | June 2020 | June 2024 | Abandon | 48 | 4 | 0 | No | No |
| 15930290 | METHODS FOR FORMING AN INVASIVE DEPLOYABLE TRANSDUCER USING SHAPE MEMORY POLYMER | May 2020 | September 2024 | Allow | 52 | 4 | 0 | Yes | No |
| 16848244 | Medical Analyzer Using Mixed Model Inversions | April 2020 | March 2024 | Allow | 47 | 2 | 1 | No | No |
| 16753887 | COHERENCE GATED PHOTOACOUSTIC REMOTE SENSING (CG-PARS) | April 2020 | September 2024 | Abandon | 53 | 3 | 0 | Yes | No |
| 16631760 | SYSTEMS AND METHODS FOR POSITIONING AN INTRACRANIAL DEVICE USING BRAIN ACTIVITY | January 2020 | January 2025 | Abandon | 60 | 3 | 1 | No | No |
| 16708493 | TRACKING SYSTEM AND MARKER DEVICE TO BE TRACKED BY THE TRACKING SYSTEM | December 2019 | December 2023 | Allow | 49 | 4 | 0 | No | No |
| 16691388 | THERMAL FIELD SCANNER | November 2019 | October 2024 | Abandon | 59 | 4 | 0 | No | No |
| 16612767 | DEVICE FOR DETERMINING A PARAMETER FOR DIAGNOSING HYDROCEPHALUS AND OTHER DISORDERS OF INTRACRANIAL PRESSURE | November 2019 | January 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 16495593 | ANNULAR INTEGRATED CIRCUIT CONTROLLER FOR INTRALUMINAL ULTRASOUND IMAGING DEVICE | September 2019 | August 2024 | Allow | 59 | 5 | 0 | Yes | No |
| 16428716 | SENSOR INTERFACE DEVICE PROVIDING DIGITAL PROCESSING OF INTRAVASCULAR FLOW AND PRESSURE DATA | May 2019 | August 2024 | Allow | 60 | 3 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner MCDONALD, JAMES F works in Art Unit 3797 and has examined 16 patent applications in our dataset. With an allowance rate of 50.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner MCDONALD, JAMES F's allowance rate of 50.0% places them in the 14% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by MCDONALD, JAMES F receive 3.31 office actions before reaching final disposition. This places the examiner in the 89% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by MCDONALD, JAMES F is 52 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +38.1% benefit to allowance rate for applications examined by MCDONALD, JAMES F. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 19.4% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 18.2% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.